Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy

Obstetrics and Gynecology

Volumn 100, Issue 3, 2002, Pages 445-450

  Mount, Sharon L ^a,c   Wegner, Elisabeth K ^b   Eltabbakh, Gamal H ^b   Olmstead, Jennifer I ^a   Drejet, Anne E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BIOPSY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; FEMALE; FOLLOW UP; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POSTMENOPAUSE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS;

EID: 0036710980     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02095-1     Document Type: Article

References (16)

1. Gondos B., King E.G. Significance of endometrial cells in cervicovaginal smears. Am Clin Lab Sci. 7:1977;486-490.
2. Gray J.A., Nguyen G.K. Cytologic detection of endometrial pathology by Pap smears. Diagn Cytopathol. 20:1999;181-182.
3. Bethesda 2001 Endometrial Forum Group Workshop Summary. Available at: http://bethesda2001.cancer.gov/postwrkshp_recs.html. Accessed 2002 Jul 22.
4. American College of Obstetricians and Gynecologists. Hormone replacement therapy. ACOG educational bulletin no. 247. 1998;American College of Obstetricians and Gynecologists, Washington, DC.
5. Kurman R.J. Blaustein's pathology of the female genital tract. 4th ed: 1994;Springer-Verlag, New York.
6. Kurman R.J., Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses Definitions, criteria and explanatory notes for terminology and specimen adequacy. 1994;Springer-Verlag, New York.
7. Sarode V.R., Rader A.E., Rose P.G., Rodriguez M., Abdul-Karim F.W. Significance of cytologically normal endometrial cells in cervical smears from postmenopausal women. Acta Cytol. 45:2001;153-156.
8. Yancey M., Magelssen D., Demaurez A., Lee R.B. Classification of endometrial cells on cervical cytology. Obstet Gynecol. 76:1990;1000-1005.
9. Ng A.B. The cellular detection of endometrial carcinoma and its precursors. Gynecol Oncol. 2:1974;162-179.
10. Cherkis R.C., Patten S.F., Andrews T.J., Dickinson J.C., Patten F.W. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol. 71:1988;242-244.
11. Chang A., Sandweiss L., Bose S. Cytologically benign endometrial cells in the Papanicolaou smears of postmenopausal women. Gynecol Oncol. 80:2001;37-43.
12. Montz R.J. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol. 81:2001;33-39.
13. Gomez-Fernandez C.R., Ganjei-Azar P., Capote-Dishaw J., Averette H.E., Nadji M. Reporting normal endometrial cells in Pap smears An outcome appraisal. Gynecol Oncol. 74:1999;381-384.
14. Kerpsack J.T., Finan M.A., Kline R.C. Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma. Southern Med J. 91:1998;749-752.
15. Gomez-Fernandez C.R., Ganjei-Azar P., Behshid K., Averette H.E., Nadji M. Normal endometrial cells in Papanicolaou smears Prevalence in women with and without endometrial disease. Obstet Gynecol. 96:2000;874-878.
16. Van den Bosch T., Vandendael A., Wranz P.A., Lombard C.J. Cervical cytology in menopausal women at high risk for endometrial disease. Eur J Cancer Prev. 7:1998;149-152.